We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens Acquires CADVision Medical Technologies

By HospiMedica staff writers
Posted on 02 Aug 2004
Siemens Medical Systems (Erlangen, Germany; www.medical.siemens.com) has recently acquired CADVision Medical Technologies (Jerusalem, Israel, www.cadvisionmed.com).

CADVision is a small research and development company that offers a unique mammography computer (CAD) system to aid in the detection and analysis of breast lesions. The technology is based on patented algorithms that enable the detection of breast lesions in combination with advanced classification capabilities. The technology is currently undergoing clinical validation.

Siemens is in the process of developing CAD technologies for several imaging applications across multiple modalities, and expects this acquisition to further strengthen its CAD product portfolio.




Related Links:
Siemens Medical Systems
CADVision Medical Technologies
MRI System
nanoScan MRI 3T/7T
Breast Localization System
MAMMOREP LOOP
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Digital Radiographic System
OMNERA 300M

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.